Imagine receiving genetic test results for a disease you could develop later in life without having anyone with whom to discuss your options for managing the risk.
In the current issue of PLOS Genetics, Michigan State University genetic scientists have begun to understand how the rest of the genome interacts with such mutations to cause the differences we see among individuals.
The genetic disease ARVC leads to sudden cardiac death and is more common than it has been hitherto assumed. This is reported by an international team of researchers headed by Prof Dr Hendrik Milting from the Heart and Diabetes Center NRW in the "European Heart Journal".
Key decisions in the genetic shuffling that occurs before eggs or sperm are formed are made earlier than thought, rewriting textbook genetics, according to recent papers from researchers at UC Davis, Harvard University and UC San Diego.
The ability of molecular biologists to sequence the human genetic code promises to usher in a new era of genetic medicine, but that doesn’t mean science can accurately read personal genetic codes.
By injecting a customized "genetic patch" into early stage fish embryos, researchers at Washington University School of Medicine in St. Louis were able to correct a genetic mutation so the embryos developed normally.
An Australian study of families with genetic risk of bowel cancer has found that 50 percent of participants declined genetic testing when informed of insurance implications.
Correlagen Diagnostics Inc., a leading provider of genetic testing for disease diagnosis, today announced the acquisition of a system from and a scientific collaboration with Helicos BioSciences Corporation.